Skip to main content
. 2019 Mar 15;20(6):1324. doi: 10.3390/ijms20061324
APD action potential duration
CiPA comprehensive in vitro proarrhythmia assay
Cmax maximal concentration
cQT concentration QT modelling
ECG electrocardiogram
FDA Food and Drug Administration
hERG human ether a-go-go related gene
ICH International Conference on Harmonization
LQTS long QT syndrome
MAD multiple ascending dose
NCE new chemical entity
QTc corrected QT
SAD single ascending dose
SCD sudden cardiac death
SQTS short QT syndrome
TdP Torsades de Pointes
TQT thorough QT